Does Improved Insulin Sensitivity By Irbesartan At The Highest Tolerated Dose Provide A Benefit In Non-Diabetic Patients With Systolic Heart Failure Already Receiving Standardized Treatment?
INTERNATIONAL JOURNAL OF CARDIOLOGY（2013）
关键词
Chronic heart failure, Irbesartan, Insulin sensitivity, Systolic blood pressure, Asymmetric dimethylarginine, Tumor necrosis factor-alpha
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要